International Society For Neglected Tropical Diseases (ISNTD)

The Barcelona Supercomputing Center Global Health Resilience group is looking for a Climate & Health Data Scientist to support our Wellcome Trust funded digital technology projects HARMONIZE and IDExtremes. Application details here: https://lnkd.in/dP4NpAPA

As 2024 comes to a close, officially reported #dengue cases are set to surpass all previous records. There have been over 12 million cases worldwide this year—a 24-fold increase since 2000—making dengue the world’s fastest-growing mosquito-borne disease, now exacerbated by #climatechange. A year ago, at #COP28 in Dubai, with the world’s attention firmly on the accelerating impact of climate on health, nearly 30 global stakeholders came together to begin a transformative journey towards helping to reduce the burden of dengue. Now, we celebrate the anniversary of this meeting and the conception of the Collective Action on Dengue initiative, a unique collaboration that brings together experts from academia, industry, foundations, NGOs and more, dedicated to tackling the rising impact of dengue. A group of organizations, including Asia Dengue Voice & Action (ADVA) Group, Duke-NUS Medical School, FIND, International Society For Neglected Tropical Diseases (ISNTD), International Society for Urban Health (ISUH), Malaria No More, MSD, Sabin Vaccine Institute, Takeda, Vista Health Pte Ltd and World Mosquito Program (WMP) are working together to advance this initiative, laser focused on the Collective Action on Dengue's three strategic pillars—Urbanization, Innovation and Advocacy—to engage communities and contribute to building resilience against the spread of dengue. Keep an eye out for updates on the strides we're making towards tackling this public health threat— more exciting developments to come!

I am happy to share that today we launched our public consultation to jointly start defining four dimensions of the noma road map 2030 with you! 🤗 If you have any ideas, insights or thoughts about where noma stands in terms of: - Diagnostics - Monitoring and evaluation - Access and logistics - Advocacy and funding Please fill in our questionnaire and help us move forward together! Also, feel free to share the link with everyone who might contribute. 🌍 It is available in 7 languages 🎉 https://lnkd.in/eYCWhmbg

💯 Join us on Dec 18th at 14:00UTC for the 100th #ISNTDConnect! 💯 In 2020, as the 2020 COVID19 worldwide lockdowns were announced, the #ISNTDConnect webinars were launched. We are so grateful at ISNTD for this amazing journey and the incredible opportunity it has been to meet fantastic colleagues from around the world, build partnerships, share research, engage in meaningful discussions and learn about a whole range of diseases and disciplines in tropical and neglected diseases. Nearly five years later, we are delighted to be coming up to the 100th ISNTD Connect, and the topic could only be about the one thing that makes this series so special... you! Coinciding with 2024 coming to a close, it seemed befitting to have an informal end-of-year meeting on Dec 18th at 14:00 CET where we will be so happy to celebrate this milestone with you, wrap up another exciting year and catch up. Grab a hot drink and join us to share your news of the past year, or what's in the works for you for 2025.  100th ISNTD Connect celebration! Dec 18 | 14:00-14:45 UTC Zoom meeting link: https://lnkd.in/e7abHTtd Discover the many topics and speakers from all ISNTD Connect sessions Watch the ISNTD Connect collection here: https://lnkd.in/eUaMJBFq ISNTD You Tube channel for all ISNTD Connect videos and more than 800+ videos from our conferences on infectious and tropical diseases: https://lnkd.in/ecF7izkm We are so truly grateful for your invaluable contributions and support whether as presenters or audience; it's been an amazing experience and pleasure to learn from you. We hope to welcome you and toast this amazing collegial network!

New data is now freely available on our #GFINDER portal showing the 2023 funding for global health R&D by: - disease or condition - product - funder - recipient - funder and recipient country - R&D stage 1️⃣See where the money is coming from and where it's going to 2️⃣Explore which new products and technologies are benefitting from investment 3️⃣Find out which diseases and conditions will be tackled with greater R&D 4️⃣Identify where funding gaps exist ❗New: Expanded coverage of the funding going to sexual & reproductive health conditions, now including: - abortion - endometriosis - menopause - polycystic ovary syndrome - uterine fibroids - maternal iron-deficiency anaemia - preterm labour https://bit.ly/4f5WFsK

✨ One year on: celebrating the inclusion of #Noma on the WHO's Neglected Tropical Diseases list ✨ Exactly one year ago, the World Health Organization announced the historic decision to officially recognize noma as a NTD. The decades-long advocacy, accelerating in the last five years and culminating in this recognition in the fight against a devastating disease, can't be overstated. Noma, both preventable and treatable, is a severe gangrenous disease of the mouth and face, long overlooked and underfunded. Today, we celebrate progress made in the undeniable increased global awareness and momentum dedicated to combating noma. It is not only the speed but also the immense variety in advocacy that is remarkable; there are several lessons in this for the global health community. Noma now sits at the intersection of sectors including #NTDs, #NCD, #oralhealth, #nutrition, #ChildHealth, #CommunityHealth, #HumanRights to name a few; this allows for advocacy, research and programs to draw on manifold experiences and resources. Stakeholders have come together in myriad ways this year: examples include a pivotal event at Geneva Health Forum #WHA77; a "Spotlight on Noma" by International Society For Neglected Tropical Diseases (ISNTD); further screenings of the award-winning documentary "Restoring Dignity" Inediz Médecins Sans Frontières (MSF) and frequent media presence. Additionally, the Swiss Tropical and Public Health Institute convened a symposium to define the noma #research agenda for better understanding, prevention and treatment. The WHO hosted its first global conference to accelerate integrating oral health into broader #publichealth. Throughout all this, one cannot highlight enough the ongoing and tireless work by those on the ground in challenging environments to ensure that affected persons receive adequate care and elusive cases continue to be detected. What really sets this community apart, however, is how survivors themselves have not only been central to but in fact led the noma effort. Noma survivors Mulikat Okanlawon and Fidel Strub are at the helm of Elysium Noma Survivors Association and were recognised internationally as TIME 100 Most Influential People in Global Health 2024. It is not only a moral imperative and collective responsibility to ensure affected persons' voices are central to any health policy and strategies, it is also the most successful way to ensure that interventions meet the actual needs of those affected. This inspirational blueprint needs to be replicated across all sectors in public health. As 2025 looms, more is needed: let's continue to support the efforts of those working tirelessly to provide early detection, treatment and care for those affected by noma. I'm excited that together we can make a difference and ensure that no one suffers from this disease. #WHO #HealthForAll #beatNTDs #GlobalHealth For more information, ISNTD Noma playlist: https://lnkd.in/e69TGsna

We've got a new paper on future chikungunya risk in Dominican Republic, based on a large 2021 antibody survey: https://lnkd.in/e37sd3g3 And if you're interested in applying this kind of analysis to other questions, here's an R walkthrough: https://lnkd.in/eA8Eczgs

Sri Lanka is experiencing extreme weather events of increasing frequency and magnitude, unlike before. With this comes the threat of dengue and potential to develop disease clusters and outbreaks in highly vulnerable areas across the island. Therefore, keeping the communities informed of the impending threat and how to mitigate such are vital steps in saving lives from dengue. I recently participated in a TV Interview on the 'Rising Threat of Dengue Amidst the Inclement Weather' at TV 1 of Sirasa, one of the most watched current affairs programmes in prime time TV. My talk was based on three key messages to the public, 1. Early referral to a doctor or a hospital is essential to prevent complications and deaths in dengue 2. Refrain from taking over the counter drugs such as pain killers (NSAIDs) to relieve pain and fever in Dengue 3. Be mindful not only about the environmental cleanliness of your home but also your child's school, office or work station, religious places and public spaces which are considered high risk premises for dengue breeding. To watch the full video of the interview : https://lnkd.in/g_HZ37Bm #publichealth #dengue #dengueprevention #riskcommunication

Test & Treat strategies for #schistosomiasis: In the run-up to Universal Health Coverage Day 2024 #UHCDay, please join the upcoming #ISNTDConnect session on Dec 10th in collaboration with the Global Schistosomiasis Alliance, outlining exciting advances in Test & Treat strategies for schistosomiasis. As schistosomiasis prevalence decreases, alternatives to Mass Drug Administration are needed, particularly to ensure that those in need of treatment receive treatment, and that schistosomiasis infections rates do not bounce back to higher levels. Test and treat strategies can be an important part of the surveillance-response approach to sustain schistosomiasis elimination as a public health problem and an important tool to support targeted health investment by governments as highlighted by this year's UHC day. We are delighted to welcome Dr Steffi Knopp (Swiss Tropical and Public Health Institute), Dr Lydia Trippler (University of Glasgow) and Florence Wakesho (Ministry of Health, Kenya) who will present findings from the SchistoBreak S. haematobium project in Pemba, Zanzibar, Tanzania and also discuss research-in-progress for S. mansoni in Kenya. Dec 10, 14:00-15:30 UTC | Register here: https://lnkd.in/dm5n5et #diagnostics #Dx #UniversalHealthDay #UCH2024 #beatNTDs #globalhealth #Kenya #tropicaldiseases #parasitology

A new species of #Trichuris (whipworm) with zoonotic potential was first discovered in a human in Côte d'Ivoire - and later identified also in Uganda, Cameroon and Laos - and named T. incognita (see the pre-prints here https://lnkd.in/eCqTdsw3). In addition to T. trichiura, the main cause of human #trichuriasis, several other members of the genus are suspected of being transmitted from animals to humans, notably T. vulpis (in the picture below you can see the eggs in comparison with those of T. trichiura) and T. suis. However, given the known difficulties in correctly identifying Trichuris species on the basis of morphology alone, data on zoonotic trichuriasis are still scarce and it is likely that other species will be discovered in the future with the application of molecular techniques. Investigations led to the identification of the new species, both in humans and pigs, in an area of southern Côte d'Ivoire where resistance to the anthelmintic combination of #ivermectin and #albendazole had emerged, making the researchers suspicious. In fact, T. incognita proved to be resistant to the combination of the two drugs (https://lnkd.in/euFXKY6J ), and this should lead us to seriously consider the use - in some cases it is more an “abuse” - of both macrocyclic lactones and benzimidazoles in countries with the most difficult socio-sanitary conditions. We have belatedly learnt the lesson of #antibioticresistance, but we do not seem to have learnt the lesson of how not using antihelminthics: a massive use of the same drugs for decades in both veterinary and human medicine, drugs that are also spread in the environment where they interact with other non-target species, what could possibly go wrong? #zoonosis #trichurisincognita #whipworminfection